Clinical Trial Update: Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea [Phase 2]

View source ↗

Summary

Phase 2 trial update for fentanyl pectin nasal spray in exercise-induced breakthrough dyspnea among patients with advanced cancers; study completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Exercise-induced Dyspnea

Drugs mentioned

• Fentanyl Pectin Nasal Spray (fentanyl)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers | Phase 2 | Status: COMPLETED | Results posted: 2020-09-04